Fig. 5
Expression, prognostic and functional analysis of INHBA. (A,B,D) The expression levels of INHBA in validation set GSE42743, GSE75538 and TCGA_HNSC. (C) The expression level of INHBA detected by RT-qPCR in clinical sample. (E) Kaplan-Meier curve to show the disease-free survival of HNSCC patients in low INHBA expression and high INHBA expression subgroups. (F) Kaplan–Meier Curves for disease-specific survival of INHBA high-expression and INHBA low-expression subgroups. (G) Kaplan-Meier curve to show the progress-free survival of HNSCC patients in low INHBA expression and high INHBA expression subgroup. (H) Kaplan-Meier curve to show the overall survival of HNSCC patients in low INHBA expression and high INHBA expression subgroups. (I) GSEA analyzed gene characteristics between INHBA low expression subgroup and INHBA high expression subgroup, located on the right and left side, respectively. (J,K) The enrichment of INHBA was analyzed by GO and KEGG. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
